Example: Heart Attack

Search clinical trials for: Carmustine

Total 168 results

NCT00795665

Completed

Bevacizumab and Carmustine in Treating Patients With Relapsed or Progressive High-Grade Glioma

Conditions: Glioma
NCT00003176

Completed

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Conditions: Brain and Central Nervous System Tumors
NCT00005855

Completed

Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma

Conditions: Brain and Central Nervous System Tumors
NCT00005637

Completed

Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma

Conditions: Brain and Central Nervous System Tumors
NCT04222062

Recruiting

A Study Comparing GLIADEL to Stereotactic Radiosurgery in Metastatic Brain Disease

Conditions: Brain Tumor - Metastatic
NCT01637753

Unknown status

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma

Conditions: Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Glioblastoma
NCT01692691

Terminated

Dacarbazine and Carmustine in Metastatic Melanoma

Conditions: Melanoma Metastatic
NCT00046878

Withdrawn

Carmustine and O(6)-Benzylguanine in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Conditions: Brain and Central Nervous System Tumors
NCT00005081

Completed

Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma

Conditions: Brain and Central Nervous System Tumors
NCT00005066

Completed

O6-benzylguanine and Carmustine in Treating Patients With Recurrent, Metastatic, or Locally Advanced Soft Tissue Sarcoma

Conditions: Sarcoma
NCT00004688

Completed

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

Conditions: Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Mixed Gliomas, Glioblastoma Multiforme, Recurrent Brain Tumor
NCT00002988

Completed

Irinotecan Plus Carmustine in Treating Patients With Recurrent Primary Malignant Glioma

Conditions: Brain and Central Nervous System Tumors
NCT00002986

Completed

Chemotherapy in Treating Patients With Recurrent Malignant Glioma

Conditions: Brain and Central Nervous System Tumors
NCT00003765

Completed

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

Conditions: Brain and Central Nervous System Tumors
NCT00003417

Completed

Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme

Conditions: Brain and Central Nervous System Tumors
NCT00003348

Completed

Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain

Conditions: Brain and Central Nervous System Tumors
NCT00003346

Completed

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Conditions: Melanoma (Skin)
NCT00004072

Completed

O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma

Conditions: Multiple Myeloma and Plasma Cell Neoplasm
NCT00004028

Completed

Carmustine in Treating Patients With Recurrent Malignant Glioma

Conditions: Brain and Central Nervous System Tumors
NCT00005981

Completed

Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Conditions: Colorectal Cancer
NCT00005961

Completed

O6-benzylguanine and Carmustine in Treating Patients With Unresectable Locally Recurrent or Metastatic Melanoma

Conditions: Melanoma (Skin)
NCT00003467

Completed

Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma

Conditions: Brain and Central Nervous System Tumors
NCT01656980

Unknown status

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma

Conditions: Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Glioblastoma
NCT00086879

Completed

Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme

Conditions: Brain and Central Nervous System Tumors
NCT00003463

Completed

Carmustine Wafers Plus Irinotecan in Treating Patients With Recurrent Supratentorial High Grade Gliomas

Conditions: Brain and Central Nervous System Tumors